Safety of accelerated infusion of nivolumab and pembrolizumab
2025 · European Journal of Cancer · 5 citations
https://doi.org/10.1016/j.ejca.2025.115373
S
Sarah R. Verhoeff
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
29
Papers
366
Citations
7
h-index
7
i10-index
Sarah R. Verhoeff is an academic researcher from Zuyderland Medisch Centrum. The author has contributed to research in topics: Renal cell carcinoma treatment & Radiomics and Machine Learning in Medical Imaging & Renal and related cancers. The author has an h-index of 7, co-authored 25 publications.
ORCID: 0000-0003-4679-8938Papers by this author
worksClinical predictors of pseudoprogression in glioblastoma: a retrospective cohort analysis
2025 · Journal of Neuro-Oncology · 1 citations
https://doi.org/10.1007/s11060-025-05299-0
Lesion detection by ceCT, 89Zr-girentuximab and FDG PET/CT in newly diagnosed patients (pts) with metastatic clear cell renal cell carcinoma (mccRCC)
2018 · Annals of Oncology · 0 citations
https://doi.org/10.1093/annonc/mdy283.097
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat